- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02903862
Health-eBrain Study (HeB)
Caregivers Virtual Health eBrain Study II
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study will track the mental status and cognition of caregivers with and without the Mindoula and DANA intervention and use subject feedback to aid in designing future interventions for caregivers.
This is a remotely administered, virtual study targeting dementia caregivers who are mild to moderately depressed. Screening calls for online administration of four surveys to determine inclusion in the study arms. These surveys will be taken on the Health-eBrain website, both at baseline/screening and throughout participation. All other participation will be completed on the participant's mobile phone, and all psychological and cognitive tests will be self-administered.
This study has a between-group design. Participants will be screened for eligibility and then randomized into each arm. The intervention arm will receive the Mindoula plus DANA intervention. The wait list control arm will take the psychological surveys at regular intervals then, after 12 weeks, be enrolled in the DANA-only observation group. The DANA-only group will take DANA and a usability questionnaire.
Studietyp
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Maryland
-
Silver Spring, Maryland, Förenta staterna, 20910
- AnthroTronix Inc
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Females and males who regularly provide care for a person with Alzheimer's Disease
- Between the ages of 45-75
- Self-reported ability to speak and read English
- Providing care for at least a year
Participants in the Intervention and Waitlist Control Arms must meet the following additional inclusion criteria:
- Zarit Burden Inventory (ZBI) Score of 9+
- Overall M3 score of 33+
- M3 Depression score of 7+
- Female Only
- Minimum hours of caregiving a week must be equal to or greater than 20 hours
Exclusion Criteria:
- Anyone with a known cognitive diagnosis
- Anyone with color blindness
- Overall score of high risk on the M3 and/or high risk on the PTSD or Bipolar subsection of the M3
- Failure to meet all inclusion criteria per arm
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Intervention Arm
Participants will receive the intervention, Mindoula plus DANA, which involves working with a case manager via an app for 12 weeks.
The case manager will help the participant cope with the stresses of caregiving as well as remind them to use the DANA cognitive assessment app.
This arm will also take the study's psychological surveys.
|
The Mindoula intervention is a combination of case management and a messenger application.
Case managers monitor how the participant is doing and any needs and provide 24/7 support & assistance, including care coordination, treatment adherence, and matching the participant with providers and community resources.
Each participant will be given an intake questionnaire to establish goals and behavioral health history.
Participants will use the app and work with the case manager for 12 weeks.
DANA is an FDA-cleared neurocognitive assessment software administered on a smartphone or tablet to measure changes in cognitive efficiency.
DANA also includes Ecological Momentary Assessments to track mood, sleep, stress, and memory.
Intervention participants will take DANA weekly.
The Waitlist Control arm will take DANA weekly 12 weeks after enrollment.
|
Övrig: Waitlist Control Arm
These participants will take psychological surveys and a usability questionnaire for the first 12 weeks of participation, then, for the 12 weeks following, take the psychological surveys along with DANA and a usability questionnaire.
|
DANA is an FDA-cleared neurocognitive assessment software administered on a smartphone or tablet to measure changes in cognitive efficiency.
DANA also includes Ecological Momentary Assessments to track mood, sleep, stress, and memory.
Intervention participants will take DANA weekly.
The Waitlist Control arm will take DANA weekly 12 weeks after enrollment.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Change from baseline M3 Behavioral Scale score over 12 weeks
Tidsram: At baseline, and 4, 8, and 12 weeks.
|
At baseline, and 4, 8, and 12 weeks.
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Change from baseline Zarit Burden Inventory score over 12 weeks
Tidsram: At baseline, and 4, 8, and 12 weeks.
|
At baseline, and 4, 8, and 12 weeks.
|
Change from baseline PROMIS Sleep Disturbance Short Form 8a score over 12 weeks
Tidsram: At baseline, and 4, 8, and 12 weeks.
|
At baseline, and 4, 8, and 12 weeks.
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Usability Questionnaire
Tidsram: At baseline, and 4, 8, and 12 weeks.
|
Survey on using DANA that will help the researchers better understand the development of technologies for this population
|
At baseline, and 4, 8, and 12 weeks.
|
Paired Associates Learning
Tidsram: At baseline and 12 weeks
|
The PAL assesses visual memory and new learning.
|
At baseline and 12 weeks
|
PERMA Profiler
Tidsram: At baseline and 12 weeks
|
This survey assesses five core element of psychological well-being and happiness - Positive emotions, Engagement, Relationships, Meaning, and Accomplishments - as well as subjective wellbeing and sense of loneliness.
|
At baseline and 12 weeks
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Corinna E Lathan, Ph.D, AnthroTronix, Inc.
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 091614A
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Depression and Burden in Caregivers
-
University Hospital, GrenobleSociété Française d'Anesthésie et de RéanimationAvslutadeFast Diagnosis Performance in Guiding First Aid Resuscitation and HemostasisFrankrike
-
Tel-Aviv Sourasky Medical CenterOkändDepression | Ångest | In vitro-fertiliseringIsrael
-
Shalvata Mental Health CenterUniversity of HaifaAvslutadDepression | Ångest | Trotssyndrom | Störande humörstörning | Uppträdande | Attention-Deficit and Hyperactivity DisorderIsrael
-
University of WashingtonNational Cancer Institute (NCI)AvslutadDepression | Steg II Bröstcancer | Steg IIIA Bröstcancer | Steg IIIB Bröstcancer | Ångestsyndrom | Psykosociala effekter av cancer och dess behandling | Steg IA Bröstcancer | Steg IB Bröstcancer | Steg IIIC Bröstcancer | Duktalt bröstkarcinom in situ | Lobulärt bröstkarcinom in situFörenta staterna
-
Szeged UniversityAvslutadCoping färdigheter | Humör | Covid-19 pandemi | Psykologisk stress | Subjektivt hälsoklagomål | Frågeformulärdesigner | Tvådelad skala för generaliserat ångestsyndrom | Patienthälsa frågeformulär Anxiety and Depression Scale | HälsostatusindexUngern
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)AvslutadDepression | Trötthet | Steg II Bröstcancer | Steg IIIA Bröstcancer | Steg IIIB Bröstcancer | Ångestsyndrom | Steg IA Bröstcancer | Steg IB Bröstcancer | Steg IIIC Bröstcancer | Duktalt bröstkarcinom in situFörenta staterna
-
Region StockholmKarolinska InstitutetRekryteringBipolär sjukdom | Bipolär depression | Bipolär störning I | Bipolär II sjukdom | Bipolär affektiv sjukdom; Remission in | Bipolär affektiv sjukdom, för närvarande deprimerad, måttligSverige
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)AvslutadDepression | Bröstcancer | Ångestsyndrom | Psykosociala effekter av cancer och dess behandlingFörenta staterna